학술논문
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial
Document Type
Article
Author
Source
In Vaccine 25 July 2024 42(19):3938-3952
Subject
Language
ISSN
0264-410X